Benjamin Cravatt

Founder & Scientific Advisor at Kojin Therapeutics

Benjamin Cravatt is Professor and Norton B. Gilula Chair of Chemical Biology in the Department of Chemistry at The Scripps Research Institute. His research group is interested in developing chemical proteomic technologies that enable protein and drug discovery on a global scale and applying these methods to characterize biochemical pathways that play important roles in human physiology and disease.

Dr. Cravatt obtained his undergraduate education at Stanford University, receiving a BS in the Biological Sciences and a BA in History. He then received a PhD from The Scripps Research Institute (TSRI) in 1996. Professor Cravatt joined the faculty at TSRI in 1997. Dr. Cravatt’s honors include a Searle Scholar Award, the Eli Lilly Award in Biological Chemistry, a Cope Scholar Award, the ASBMB Merck Award, the RSC Jeremy Knowles Award, the AACR Award for Achievement in Chemistry in Cancer Research, and memberships in the National Academies of Medicine and Sciences.

Timeline

  • Founder & Scientific Advisor

    Current role